Donepezil News
APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) Announce the Successful Completion of the Pilot Bioequivalence Study of Their Donepezil RapidFilm Further Confirming the Validity and Adaptability of This Innovative Proprietary Technolog
APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pilot bioequivalence study of their Donepezil RapidFilm™ further confirming the validity and adaptability of this...
Teva Announces Tentative Approval of Generic Aricept Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version...
Eisai Could See At-Risk Launch of Generic Aricept ODT
Eisai has lost its right to a 30-month stay on FDA approval of Mutual Pharmaceutical-United Research Laboratories’ abbreviated new drug application for Aricept ODT, an orally disintegrating tablet formulation of the Alzheimer’s...
Eisai Introduces New Aricept Dose Formulations
Japanese drugmaker Eisai has started selling new dose formulations of Aricept for the treatment of severe Alzheimer's disease in Japan.
Ranbaxy gets tentative FDA nod for Aricept copy
Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) has won tentative approval from the U.S. Food and Drug Administration to make a generic version of Eisai Co Ltd's (4523.T: Quote, Profile, Research)...